I Interni klinika; Vseobecna fakultni nemocnice

Prague 128 08

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma — Completed
• A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) — Completed